SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER 1. Date of Report (Date of earliest event reported) Jan 31, 20222. SEC Identification Number 8083. BIR Tax Identification No. 000-162-9354. Exact name of issuer as specified in its charter DITO CME HOLDINGS CORP.5. Province, country or other jurisdiction of incorporation Philippines6. Industry Classification Code(SEC Use Only) 7. Address of principal office 21st Floor, Udenna Tower, Rizal Drive corner 4th Avenue, Bonifacio Global City, Taguig CityPostal Code16348. Issuer's telephone number, including area code 632840340079. Former name or former address, if changed since last report N/A10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common 14,035,000,000
11. Indicate the item numbers reported herein Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

DITO CME Holdings Corp.DITO PSE Disclosure Form 4-32 - Reply to Exchange's Query
Subject of the Disclosure

Response to the PSE on additional information relating to the deferment of the Stock Rights Offer ("SRO")

Description of the Disclosure

Please find attached a letter by company which provides for additional information relating to the deferment of its SRO. Please also see attached the procedure for the refund of the shareholders who have participated in the SRO.

Information Requested

None

Filed on behalf by:
Name Leandro Abarquez
Designation Corporate Legal Counsel

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Dito CME Holdings Corporation published this content on 31 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 January 2022 11:59:03 UTC.